U.S. markets open in 4 hours 49 minutes
  • S&P Futures

    3,783.50
    +21.25 (+0.56%)
     
  • Dow Futures

    30,845.00
    +125.00 (+0.41%)
     
  • Nasdaq Futures

    12,914.75
    +112.50 (+0.88%)
     
  • Russell 2000 Futures

    2,142.90
    +22.10 (+1.04%)
     
  • Crude Oil

    52.35
    -0.01 (-0.02%)
     
  • Gold

    1,843.00
    +13.10 (+0.72%)
     
  • Silver

    25.36
    +0.50 (+2.01%)
     
  • EUR/USD

    1.2120
    +0.0037 (+0.30%)
     
  • 10-Yr Bond

    1.0970
    0.0000 (0.00%)
     
  • Vix

    23.23
    -0.02 (-0.09%)
     
  • GBP/USD

    1.3610
    +0.0023 (+0.17%)
     
  • USD/JPY

    103.9770
    +0.2900 (+0.28%)
     
  • BTC-USD

    37,277.75
    +836.02 (+2.29%)
     
  • CMC Crypto 200

    735.11
    -0.03 (-0.00%)
     
  • FTSE 100

    6,731.01
    +10.36 (+0.15%)
     
  • Nikkei 225

    28,633.46
    +391.25 (+1.39%)
     

Top Ranked Momentum Stocks to Buy for March 16th

Zacks Equity Research
·2 min read

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 16th:

Bicycle Therapeutics plc (BCYC): This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.

Bicycle Therapeutics PLC Sponsored ADR Price and Consensus

Bicycle Therapeutics PLC Sponsored ADR Price and Consensus
Bicycle Therapeutics PLC Sponsored ADR Price and Consensus

Bicycle Therapeutics PLC Sponsored ADR price-consensus-chart | Bicycle Therapeutics PLC Sponsored ADR Quote

Bicycle Therapeutics' shares gained 0.9% over the last one month compared to S&P 500’s fall of 19.8%. The company possesses a Momentum Score of B.

Bicycle Therapeutics PLC Sponsored ADR Price

Bicycle Therapeutics PLC Sponsored ADR Price
Bicycle Therapeutics PLC Sponsored ADR Price

Bicycle Therapeutics PLC Sponsored ADR price | Bicycle Therapeutics PLC Sponsored ADR Quote

Co-Diagnostics, Inc. (CODX): This molecular diagnostics company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.

Co-Diagnostics, Inc. Price and Consensus

Co-Diagnostics, Inc. Price and Consensus
Co-Diagnostics, Inc. Price and Consensus

Co-Diagnostics, Inc. price-consensus-chart | Co-Diagnostics, Inc. Quote

Co-Diagnostics’ shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.

Co-Diagnostics, Inc. Price

Co-Diagnostics, Inc. Price
Co-Diagnostics, Inc. Price

Co-Diagnostics, Inc. price | Co-Diagnostics, Inc. Quote

Zeons Corporation (ZEON): This producer of bio fuels, including fuels for diesel, gasoline, and natural gas engines from agricultural feed stocks, such as soybeans and corn has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Zeons Corporation Price and Consensus

Zeons Corporation Price and Consensus
Zeons Corporation Price and Consensus

Zeons Corporation price-consensus-chart | Zeons Corporation Quote

Zeons’ shares gained 95% over the last one month. The company possesses a Momentum Score of B.

Zeons Corporation Price

Zeons Corporation Price
Zeons Corporation Price

Zeons Corporation price | Zeons Corporation Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Zeons Corporation (ZEON) : Free Stock Analysis Report
 
Co-Diagnostics, Inc. (CODX) : Free Stock Analysis Report
 
Bicycle Therapeutics PLC Sponsored ADR (BCYC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research